Antiviral activity of dolutegravir in subjects with failure on an integrase inhibitor-based regimen: Week 24 phase 3 results from VIKING-3

Authors
Category Primary study
ConferenceJournal of the International AIDS Society
Year 2012
This article has no abstract
Epistemonikos ID: 4f2510d82414f889e5646a73ac560bca6d7aadff
First added on: Mar 06, 2026